Company Aggregate Debt: ChromaDex Corporation (NAGE)

Chromadex Corp (NAGE) creates innovative medical solutions. This chart of the asset's market value on GURU.Markets confirms the efficiency of automating the synthesis of longevity components, where the indicator stands at 0.00. Profit protection is ensured by exclusive patents for Niagen, which block the replication of technologies. Simultaneously, the company is expanding its presence by supplying raw materials for dietary supplements to global corporations and developing its own retail brand.

This metric measures the equity value of total debt to analyze the alignment of credit load with operating expenses. For Chromadex Corp (NAGE), this is critical when financing nicotinamide riboside patents and developing anti-aging supplements. The trend in total debt volume reveals the efficiency of liquidity management. A divergence between the reduction of liabilities and falling profits signals a capital freeze. This allows for an objective assessment of the company's asset quality.